Fredericks C, Kvam K, Bear J, Crabtree G, Josephson S. A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab. Lupus 2014 (in press).
2.
van ZelmMCSmetJAdamsB. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest2010; 120: 1265–1274.
3.
KurokiKTsuchiyaNTsaoBP. Polymorphisms of human CD19 gene: Possible association with susceptibility to systemic lupus erythematosus in Japanese. Genes Immun2002; 3(Suppl. 1): S21–S30.
4.
van ZelmMCReisliIvan der BurgM. An antibody-deficiency syndrome due to mutations in the CD19 Gene. N Engl J Med2006; 354: 1901–1912.
5.
ArtacHReisliIKaraR. B-cell maturation and antibody responses in individuals carrying a mutated CD19 allele. Genes Immun2010; 11: 523–530.
6.
MeiHESchmidtSDörnerT. Rationale of anti-CD19 immunotherapy: An option to target autoreactive plasma cells in autoimmunity. Arthritis Res Ther2012; 14(Suppl. 5): S1–S1.
7.
Del NagroCJOteroDCAnzelonANOmoriSAKollaRVRickertRC. CD19 function in central and peripheral B-cell development. Immunol Res2005; 31: 119–131.
MéletJMullemanDGoupillePRibourtoutBWatierHThibaultG. Rituximab-induced T cell depletion in patients with rheumatoid arthritis: Association with clinical response. Arthritis Rheum2013; 65: 2783–2790.
